Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
42 studies found for:    "neurohypophyseal diabetes insipidus" OR "Diabetes Insipidus"
Show Display Options
Rank Status Study
1 Completed Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
Conditions: Diabetes Insipidus;   Diabetes Insipidus, Neurohypophyseal
Interventions: Drug: chlorpropamide;   Drug: desmopressin
2 Completed A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).
Condition: Central Diabetes Insipidus
Interventions: Drug: Desmopressin Oral Melt;   Drug: Desmopressin intranasal
3 Recruiting Metformin and Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus
Intervention: Drug: Metformin
4 Completed Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Condition: Nephrogenic Diabetes Insipidus
Interventions: Drug: sildenafil;   Drug: calcitonin;   Drug: hydrochlorothiazide/amiloride;   Drug: indomethacin;   Drug: Placebo for sildenafil;   Drug: placebo for calcitonin
5 Completed Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study
Condition: Diabetes Insipidus
Intervention:
6 Recruiting Use of Copeptin in Diabetes Insipidus
Conditions: Diabetes Insipidus (Central and Nephrogen);   Primary Polydipsia
Interventions: Other: Water deprivation test;   Other: Water deprivationtest;   Other: Hypertonic saline infusion
7 Completed Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus, Nephrogenic
Intervention: Drug: chlorothiazide
8 Unknown  Study of Novel Types of Familial Diabetes Insipidus
Condition: Diabetes Insipidus
Intervention: Drug: desmopressin
9 Completed
Has Results
A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Condition: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Intervention: Drug: tolvaptan
10 Recruiting Wolfram Syndrome International Registry and Clinical Study
Conditions: Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
Intervention:
11 Completed Effect of Statin Treatment on Urinary AQP2 (uAQP2/01)
Conditions: Hypercholesterolemia;   Diabetes Insipidus
Intervention:
12 Recruiting Tracking Neurodegeneration in Early Wolfram Syndrome
Conditions: Type 1 Diabetes;   Diabetes Insipidus;   Diabetes Mellitus;   Wolfram Syndrome
Intervention:
13 Recruiting Shared Health Appointments and Reciprocal Enhanced Support
Condition: Diabetes Insipidus
Intervention:
14 Completed Vasopressin Deficiency in Hemorrhagic Shock
Condition: Body Response to Trauma
Intervention: Other: Phlebotomy
15 Completed Regulation of Arginine-vasopressin (AVP)
Conditions: Schizophrenia;   Depression
Intervention: Other: Procedural
16 Terminated Oxytocin and Arginine Vasopressin in Pain Relief
Condition: Placebo Analgesia
Intervention:
17 Recruiting AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Condition: Traumatic Shock
Intervention: Drug: Vasopressin
18 Completed
Has Results
1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy
Condition: Kidney Failure
Interventions: Drug: DDAVP;   Drug: saline solution
19 Completed The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration
Condition: Exercise Induced Hyponatremia
Interventions: Dietary Supplement: Gatorade Endurance Formula;   Other: ganirelix acetate
20 Completed Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Inappropriate ADH Syndrome;   Hyponatremia
Intervention: Drug: SR121463B

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years